halofantrine
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Halfan |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a603030 |
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | 60–70% |
| Metabolism | Hepatic (CYP3A4-mediated) |
| Elimination half-life | 6–10 days |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H30Cl2F3NO |
| Molar mass | 500.427209489 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Főnév
halofantrine (tsz. halofantrines)
- halofantrine - Szótár.net (en-hu)
- halofantrine - Sztaki (en-hu)
- halofantrine - Merriam–Webster
- halofantrine - Cambridge
- halofantrine - WordNet
- halofantrine - Яндекс (en-ru)
- halofantrine - Google (en-hu)
- halofantrine - Wikidata
- halofantrine - Wikipédia (angol)